IRIS
BRUGNOLO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.280
AS - Asia 1.324
NA - Nord America 574
SA - Sud America 120
AF - Africa 35
OC - Oceania 1
Totale 14.334
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.067
SG - Singapore 571
US - Stati Uniti d'America 547
CN - Cina 336
VN - Vietnam 262
FR - Francia 93
BR - Brasile 69
HK - Hong Kong 39
DE - Germania 25
FI - Finlandia 23
GB - Regno Unito 21
AR - Argentina 20
JP - Giappone 20
IQ - Iraq 15
CA - Canada 12
ID - Indonesia 12
IN - India 12
CH - Svizzera 11
EC - Ecuador 10
BD - Bangladesh 9
MX - Messico 9
PK - Pakistan 8
IE - Irlanda 7
ZA - Sudafrica 7
CO - Colombia 6
EG - Egitto 6
PH - Filippine 6
RU - Federazione Russa 6
UA - Ucraina 6
DZ - Algeria 5
MA - Marocco 5
TR - Turchia 5
CL - Cile 4
KE - Kenya 4
NL - Olanda 4
TH - Thailandia 4
TW - Taiwan 4
CR - Costa Rica 3
ES - Italia 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
BO - Bolivia 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
OM - Oman 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PL - Polonia 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 14.334
Salva come PNG Salva come JPEG
Città #
Genova 6.358
Genoa 3.437
Rapallo 1.189
Vado Ligure 913
Singapore 281
San Jose 216
Ho Chi Minh City 95
Ashburn 92
Lauterbourg 78
Hanoi 58
Beijing 52
Hong Kong 38
Bordighera 34
Frankfurt am Main 23
Helsinki 23
New York 23
Santa Clara 21
Tokyo 17
Rome 16
Orem 13
Los Angeles 11
Zurich 11
Council Bluffs 10
Milan 9
Tianjin 9
São Paulo 8
Da Nang 7
Bologna 6
Dublin 6
Hải Dương 6
Mexico City 6
Montreal 6
Haiphong 5
Jakarta 5
Paris 5
Phủ Lý 5
Baghdad 4
Cairo 4
Cardiff 4
Guayaquil 4
Johannesburg 4
Thái Nguyên 4
Amsterdam 3
Atlanta 3
Belo Horizonte 3
Changsha 3
City of London 3
Karachi 3
Lahore 3
London 3
Naples 3
Pavia 3
Poplar 3
Tashkent 3
Turin 3
Algiers 2
Bangkok 2
Bentonville 2
Biên Hòa 2
Bogotá 2
Brescia 2
Buffalo 2
Bắc Ninh 2
Bến Tre 2
Cantalupo Ligure 2
Chicago 2
Cochabamba 2
Correggio 2
Cotia 2
Córdoba 2
Dallas 2
Franca 2
Francavilla Fontana 2
Houston 2
Marseille 2
Medellín 2
Mendoza 2
Miami 2
Mosul 2
Mumbai 2
Muscat 2
Nairobi 2
New Taipei City 2
Ninh Bình 2
Palermo 2
Piscataway 2
Quito 2
Quận Ba 2
Recife 2
Rio de Janeiro 2
Shanghai 2
Staten Island 2
Toronto 2
Tucumã 2
Uberlândia 2
Vilnius 2
Điện Bàn 2
Abidjan 1
Acalanes Ridge 1
Addis Ababa 1
Totale 13.242
Salva come PNG Salva come JPEG
Nome #
An updated Italian normative dataset for the Stroop color word test (SCWT) 272
A normative study of the Italian printed word version of the free and cued selective reminding test 228
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 209
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 206
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 200
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 199
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 198
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 188
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 183
Parkinson’s Disease Sleep Scale 2: application in an Italian population 182
Cortical sources of awake scalp EEG in eating disorders 177
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 176
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 175
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 175
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 173
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 173
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 170
Early identification of MCI converting to AD: a FDG PET study 170
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 167
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 166
What predicts cognitive decline in de novo Parkinson's disease? 162
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 160
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 160
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 160
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 159
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 158
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 157
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 154
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. 151
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 150
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 149
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 149
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 148
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 148
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 147
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 145
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 144
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 144
Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes 144
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 143
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 142
The Von Restorff effect in ageing and Alzheimer's disease. 142
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 141
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 141
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 141
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 141
How can we define a brain health chart? A narrative review and a proposal 139
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 139
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 138
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 138
MCI patients declining and not declining at mid-term follow-up: FDG PET findings. Annual Congress of the European Association of Nuclear Medicine 136
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 135
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 135
The value of SPECT in detecting Alzheimer-type neurodegeneration in mild cognitive impairment 132
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 131
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 130
Cognitive function in patients with carotid stenosis: preliminary data on the use of the WAIS-R. 129
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 125
Do we need a 99mTc-ECD template for SPM SPECT studies? 124
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 122
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 122
Mapping memory impairment and conversion patterns in aMCI patients: a combined VBM and PET study 121
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 120
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic disease Clin Exp Rheumatol 119
Cognitive correlates of nigrostriatal dysfunction in de novo Parkinson’s disease (PD) 119
MMSE factorial analysis in Alzheimer’s disease. 116
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 115
SPECT-Memory correlation in very mild Alzheimer’s disease. Effect of correlation for the severity of global cognitive impairment. 115
The 16 item-printed word version of the free and cued selective reminding test (FCSRT): normal values in an italian population 115
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 115
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 112
Dehydroepiandrosterone sulphate and its correlation with clinical and hormonal parameters in eating disorders. 112
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 112
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 112
Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. 111
Metabolic Networks Involved in Cognitive Reserve in Prodromal Alzheimer's Disesase (pAD): A European Alzheimer's Disease Consortium (EADC) Project 110
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 110
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 108
Principal component analysis of FDG PET in amnestic MCI 107
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 107
Principal component analysis of FDG PET in amnestic MCI 106
Funzioni attentive nell’anoressia nervosa: dati neurofisiologici preliminar 104
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 104
Cortical sources of awakening scalp EEG in eating disorders. 103
The need of appropriate brain spect templates for spm comparisons 102
Integrated neurophysiological approach to Parkinson’s disease: preliminary data. 102
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 101
Manuale del Caregiver – Per chi si prende cura della persona malata di Alzheimer 100
Consistency of neuropsychiatric syndromes across dementias: Results from the european alzheimer disease consortium. Part ii 100
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 100
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 98
The visual search test: analysis of sensitivity of the global score and of the three items in mild Alzheimer’s disease 96
Semantic memory impairment and geographic space recognition in Alzheimer’s disease 95
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 94
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 93
Is Euro a cognitive chellenge for the elderly? 92
Evidence of posterior cortical dysfunction in de novo, drug-naïve Parkinson’s disease (PD) 92
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 92
The organization of the neuropsychiatric "macro"- UVA at IRCCS AOU "San Martino-IST", Genova. 89
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 88
Totale 13.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.703
article - articoli 36.475
book - libri 0
conference - conferenze 8.537
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 691
Totale 91.406
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 75 64 70
2021/20221.226 32 66 114 151 52 83 67 256 50 116 50 189
2022/20231.355 102 95 21 147 211 222 4 116 248 18 148 23
2023/2024785 44 104 10 91 68 139 52 42 40 22 53 120
2024/20252.335 82 164 52 160 277 280 230 358 111 114 247 260
2025/20263.536 557 141 211 304 501 297 612 219 370 324 0 0
Totale 14.482